secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2026-09-14T13:26:20+00:00
Accession:  0001628280-26-061717
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin appoints Robert Plenge to board, expanding to 11 members
-----------------------------------------------------------------

- Board increased from 10 to 11 members; Robert Plenge, M.D., Ph.D. appointed effective September 10, 2026.
- Plenge also named to Science and Technology Committee as an independent non-employee director.
- Granted RSUs valued at $400,000 under 2017 Equity Incentive Plan, vesting before next annual meeting.
- Eligible for standard non-employee director fees and committee retainers per April 21, 2026 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000162828026061717/0001628280-26-061717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000162828026061717/bmrn-20260910.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-061717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer